Thitiya Dejthevaporn , MD

Dr. Thitiya Dejthevaporn’s Story

Dr Thitiya Dejthevaporn is Assistant Professor at the Medical Oncology Unit, Department of Internal Medicine, Ramathibodi Hospital, in Bangkok, Thailand. She obtained her Doctor of Medicine (First Degree Honor) from the Mahidol University in 1991, and completed both her residency in Internal Medicine and Fellowship training in Hematology and Medical Oncology at the University of Alabama, Birmingham, USA.

Dr Dejthevaporn has special interest in breast cancer, GU cancer, brain tumor and palliative care. She has conducted clinical research in treatment of various malignancies including breast and lung cancer. She has also contributed to the development of National Practice Guidelines for breast, gastric and esophageal cancers with the National Health Security Office and National Cancer Institute. She is currently a vice president of the Thai Society of Clinical Oncology and Head of Medical Oncology Unit at Ramathibodi Hospital, Mahidol University.

Research Interest

Breast cancer, palliative care, and management of cancer in lower income setting

Department

Internal Medicine

Professional Experience

Jan 1999-present	Faculty staff, Medical Oncology Unit, Faculty of Medicine Ramathibodi Hospital, Mahidol University
July- November 1998	Clinical Instructor, Department of Internal Medicine, Division of Hematology and Oncology, University of Alabama at Birmingham, Alabama, USA
1995-1998	Fellow – Hematology and Medical Oncology, University of Alabama at Birmingham, USA
1992-1995	Resident – Internal Medicine, University of Alabama at Birmingham, USA
1985-1991	Mahidol University, Ramathibodi Hospital School of Medicine , Doctor of Medicine, First Degree Honor

Specialized field

breast cancer, palliative care, general oncology

Qualifications, certified physicians, medical specialists

American Board of Internal Medicine

American Board of Hematology

American Board of Medical Oncology

研究実績

Disparities in Access to Systemic Treatment for Breast Cancer in Thailand and Major Asian Territories. J Breast Cancer . 2022 Jun;25(3):207-217.

Ithimakin S, Parinyanitikul N, Kim SB, Yap YS, Tsang J, Soong IS, Ozaki Y, Ohno S, Ono M, Chan JJ, Cheng HC, Dejthevaporn T

• 論文

Clinical treatment score post-5 years (CTS5) as a tool for risk estimation of late recurrence in Thai patients with estrogen receptor positive, early breast cancer: A validation study

P. Patanayindee, T. Dejthevaporn

• 学会発表

Real World Experience of Long Term Treatment Outcome in Hormone Receptor-positive Metastatic Breast Cancer with or without Everolimus and Exemestane after Prior Aromatase Inhibitor.

Dajsakdipon T, Konmun J, Udomsubpayakul U, Dejthevaporn T

• 論文

Optimizing outcomes for patients with metastatic prostate cancer: insights from South East Asia Expert Panel

Fabio Augusto Barros Schutz, Ekaphop Sirachainan, Shanggar Kuppusamy, Nguyen Thi Thai Hoa, Thitiya Dejthevaporn, Badrulhisham Bahadzor, Vu Quang Toan, Phichai Chansriwong, Adlinda Alip, Nguyen Thi Minh Hue, Napa Parinyanitikul, Ai Lian Tan, Vu Dinh Khanh Hoang, Piyawan Tienchaiananda, Sai Naga Deepak Chinchapattanam, Amit Garg

• 論文